TY - JOUR
AU - ,
AB - '." Press 1991 Br. J. Cancer 985-989 Macmillan Ltd., 64, (1991), Br. J. Cancer (1991), 64, 985-989 C) Macmillan Press Ltd., 1991 GUEST EDITORIAL N. de Vries', N. van Zandwijk2, U. Pastorino3 and on behalf of the Euroscan Steering Committee* 'Department of Otolaryngology/Head and Neck Surgery, Free University Hospital, Amsterdam, The Netherlands; 2Department of Pulmonology, Netherlands Cancer Institute, Amsterdam, The Netherlands; and 3Department of Thoracic Surgery, Istituto Nazionale Milano, Italy. the head and neck, defying curative Head and neck and lung cancer treated areas within in control rates in treatment. Improvements local/regional have not resulted in a propor- of all cancers develop in the mucosa of head and neck cancer patients Approximately 5% in survival rates in these patients. The reason and neck area (Boyle et al., 1990). A substantial tional increase the head from uncontrolled disease as fewer die patients present at a moment that curative for this is that patients number of these are to the risk and more patients exposed treatment is possible, due to the fact that many head and in the head neck, distant metastases) second tumours (and neck cancers cause complaints in an early stage. The prog- of primary tumours are the most 
TI - The EUROSCAN Study
JF - British Journal of Cancer
DO - 10.1038/bjc.1991.451
DA - 1991-12-01
UR - https://www.deepdyve.com/lp/springer-journals/the-euroscan-study-YDeUr5wp7v
SP - 985
EP - 989
VL - 64
IS - 6
DP - DeepDyve
ER -